CPhI has highlighted that continuous processing, PAT (Process Analytical Technology), and PAC (Process Analytical Chemistry) are now being combined in the pharma industry order to produce better-quality products at a lower cost. This new manufacturing strategy has gained speed owing to government’s efforts to ‘reshore’ manufacturing. CPhI’s recent annual report has also predicted that China and the USA will lead the pharma market in innovations by 2030 in the backdrop of mass personalized therapeutics, cobots, AI, and automation delivering process improvements.
Read on